Table 3.
Percentage of TLR3+ cells in PBMCs
| TLR3+ cells (%) | Control (n=84) | DMED group (n=84) | t | P |
|---|---|---|---|---|
| T0 | 3.45±0.32 | 3.52±0.25 | 1.580 | 0.116 |
| T1 | 3.51±0.18 | 3.43±0.41 | 1.637 | 0.103 |
| T2 | 4.23±0.24 | 3.06±0.20 | 40.617 | 0.000 |
| T3 | 4.31±0.15 | 2.98±0.42 | 27.332 | 0.000 |
| T4 | 4.62±0.14 | 2.85±0.37 | 41.007 | 0.000 |
| F | 480.50 | 64.34 | ||
| P | 0.000 | 0.000 |
Notes: T0: before operation; T1: 30 min after anesthesia induction; T2: 24 h after operation; T3: 48 h after operation; T4: 72 h after operation; DMED: dexmedetomidine; TLR: toll-like receptor; PBMC: peripheral blood mononuclear cells.